Loading data for IPSC — first visit, this takes a few seconds.
Century Therapeutics, Inc. (IPSC)
NasdaqCM: IPSC
· 实时价格 · USD
1.94
+0.00 (0.00%)
收盘价： Sep 10, 2026, 8:00 PM
1.94
+0.00%
盘后: 7:30 PM
股价、关键数字和最新消息，都在这一页。
Century Therapeutics, Inc.（IPSC）股价、分析与数据
暂无数据
| 买价 | 1.41 |
| 市值 | 351M |
| 营收（TTM） | 0 |
| 净利润（TTM） | -110M |
| 1.60 | |
| -0.88 | |
| n/a | |
| -4.29 | |
| 市净率（TTM） | 1.51 |
| 市销率（TTM） | 0.00 |
| 财报日期 | Nov 12, 2026 |
| 卖价 | 2.43 |
| 成交量 | 465,714 |
| 20日均量 | 1,079,654 |
| 开盘价 | 1.98 |
| 前收盘价 | 1.94 |
| 日内区间 | 1.89 - 2.00 |
| 52周区间 | 0.43 - 3.04 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 IPSC
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-...
公司完整简介财报意外
Century Therapeutics 已于 Aug 12, 2026 发布季度财报：
- 营收为 $0 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 -0.11 超出预期 0.01, ， 71.05% 同比增长.
第 1 页，共 2 页